Related Experiment Video

Updated: Dec 5, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.6K

Predictive Value of Fasting Blood Glucose for Microvascular Obstruction in Nondiabetic Patients with ST-Segment

Han Wu1, Ran Li1, Kun Wang1

  • 1Department of Cardiology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.

Cardiology Research and Practice
|October 16, 2020
PubMed

Insights

In nondiabetic patients with ST-segment elevation myocardial infarction (STEMI), higher fasting blood glucose (FBG) levels predict microvascular obstruction (MVO) after primary percutaneous coronary intervention (PCI). This finding highlights FBG as a significant independent predictor of MVO.

Area of Science:

  • Cardiology
  • Biomedical Science
  • Medical Research

Background:

  • The link between fasting blood glucose (FBG) and microvascular obstruction (MVO) post-primary percutaneous coronary intervention (PCI) is not well-defined in nondiabetic ST-segment elevation myocardial infarction (STEMI) patients.
  • This knowledge gap necessitates further investigation into potential predictors of MVO in this specific patient cohort.

Purpose of the Study:

  • To investigate the predictive value of fasting blood glucose (FBG) for microvascular obstruction (MVO) in nondiabetic patients who have undergone primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).

Main Methods:

  • A cohort of 108 nondiabetic STEMI patients undergoing primary PCI was analyzed.
  • Patients were categorized into microvascular obstruction (MVO) and non-MVO groups using cardiac magnetic resonance imaging (CMR) for assessment.

Main Results:

  • Fasting blood glucose (FBG) levels were significantly higher in the microvascular obstruction (MVO) group compared to the non-MVO group.
  • Univariate analysis identified FBG, peak high-sensitive troponin T (TnT), pre-PCI thrombolysis in myocardial infarction (TIMI) flow, left ventricular ejection fraction (LVEF), infarction size, left ventricular end-diastolic diameter (LVEDd), left ventricular end-diastolic volume (LVEDV), and global longitudinal strain (GLS) as potential MVO predictors.
  • Following adjustment for other variables, FBG, peak TnT, LVEF, and LVEDV emerged as independent predictors of MVO.

Conclusions:

  • Fasting blood glucose (FBG) is independently associated with the presence of microvascular obstruction (MVO) in nondiabetic patients experiencing ST-segment elevation myocardial infarction (STEMI).
  • FBG may serve as a valuable predictive marker for MVO in this population, guiding clinical management strategies.
Abstract

More Related Videos

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.5K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
631
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
117
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
451